Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms?
ContributorsClement, Sophie; Peyrou, Marion; Foti, Michelangelo
Published inJournal of clinical oncology, vol. 31, no. 32, p. 4160-4161
Publication date2013
Keywords
- Carcinoma, Hepatocellular/etiology
- Female
- Hepatitis C/complications
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects
- Liver Neoplasms/etiology
- Male
Citation (ISO format)
CLEMENT, Sophie et al. Statins may protect against hepatocellular carcinoma development in patients infected with hepatitis C virus, but what are the mechanisms? In: Journal of clinical oncology, 2013, vol. 31, n° 32, p. 4160–4161. doi: 10.1200/JCO.2013.51.0354
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:33505
- DOI : 10.1200/JCO.2013.51.0354
- PMID : 24081939
ISSN of the journal0732-183X
